Exploring the Clinical Results of MRG003 & MRG004A to Develop EFGR Targeted ADCs
Time: 8:30 am
day: Day One
Details:
- Comprehensive review of five ADCs currently in clinical studies
- Outline updated clinical results on nasopharyngeal carcinoma and HNSCC for MRG003, an EGFR targeted ADC
- Gain a clinical update for MRG004A, a TF targeted ADC
